Function and regulation of MHC class II molecules in T-lymphocytes: of mice and men.

The main function of major histocompatibility complex (MHC) class II molecules is to present processed antigens, which are derived primarily from exogenous sources, to CD4(+) T-lymphocytes. MHC class II molecules thereby are critical for the initiation of the antigen-specific immune response. Besides antigen presentation, growing evidence is showing that ligation of MHC class II molecules also activates intracellular signaling pathways, frequently leading to apoptosis. Constitutive expression of MHC class II molecules is confined to professional antigen-presenting cells (APC) of the immune system, and in nonprofessional APCs MHC class II molecules can be induced by a variety of immune regulators. Interestingly, activated T cells from many species, with the exception of mice, synthesize and express MHC class II molecules at their cell surface. In this review, we discuss our current knowledge on the transcriptional regulation of MHC class II expression in activated human and mouse T cells, and the contribution of DNA methylation of the T-cell employed class II transactivator promoter III to the MHC class II deficiency of mouse T cells. We also discuss the proposed functions of the activated T cell synthesized and expressed MHC class II molecules, including antigen presentation, T-T cell interactions, and MHC class II-mediated intracellular signaling.

[1]  H. Weiner,et al.  Reciprocal expression of co‐stimulatory molecules, B7‐1 and B7‐2, on murine T cells following activation , 1995, European journal of immunology.

[2]  G. Freeman,et al.  Early signaling defects in human T cells anergized by T cell presentation of autoantigen , 1992, The Journal of experimental medicine.

[3]  K. Bobbitt,et al.  Regulation of MHC Class II Signal Transduction by the B Cell Coreceptors CD19 and CD221 , 2000, The Journal of Immunology.

[4]  T. Wyss-Coray,et al.  T cells as antigen-presenting cells. , 1994, Immunology today.

[5]  A. Rudensky,et al.  Lysosomal cysteine proteases regulate antigen presentation , 2003, Nature Reviews Immunology.

[6]  B. Mach,et al.  Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA , 1997, The EMBO journal.

[7]  R. Lechler,et al.  Antigen presentation by mouse CD4+ T cells involving acquired MHC class II:peptide complexes: another mechanism to limit clonal expansion? , 2003, Blood.

[8]  S. Kanner,et al.  Superantigen and HLA-DR ligation induce phospholipase-C gamma 1 activation in class II+ T cells. , 1992, Journal of Immunology.

[9]  R. Lechler,et al.  Antigen presentation by T cells inhibits IL-2 production and induces IL-4 release due to altered cognate signals. , 1996, Journal of immunology.

[10]  C. Thompson,et al.  The central effectors of cell death in the immune system. , 1999, Annual review of immunology.

[11]  A. Wong,et al.  Regulation and Specificity of MHC2TA Promoter Usage in Human Primary T Lymphocytes and Cell Line1 , 2002, The Journal of Immunology.

[12]  A. Lokshin,et al.  Differential regulation of maturation and apoptosis of human monocyte-derived dendritic cells mediated by MHC class II. , 2002, International immunology.

[13]  R. Siliciano,et al.  Analysis of host-virus interactions in AIDS with anti-gp120 T cell clones: Effect of HIV sequence variation and a mechanism for CD4+ cell depletion , 1988, Cell.

[14]  E. Satyaraj,et al.  Induction of tolerance in freshly isolated alloreactive T cells by activated T cell stimulators is not due to the absence of CD28-B7 interaction. , 1995, Journal of immunology.

[15]  P. Cresswell,et al.  Negative regulation by HLA-DO of MHC class II-restricted antigen processing. , 1997, Science.

[16]  R. Lechler,et al.  Antigen presentation by keratinocytes induces tolerance in human T cells , 1990, European journal of immunology.

[17]  J. Bluestone,et al.  The B7 and CD28 receptor families. , 1994, Immunology today.

[18]  I. Cohen,et al.  Expression of major histocompatibility complex class II molecules in rat T cells , 1994, European journal of immunology.

[19]  T. Yoshino,et al.  CD80 (B7-1) and CD86 (B7-2) antigens on house dust mite-specific T cells in atopic disease function through T-T cell interactions. , 1999, The Journal of allergy and clinical immunology.

[20]  V. Barnaba,et al.  Professional presentation of antigen by activated human T cells , 1994, European journal of immunology.

[21]  P. Cresswell,et al.  HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides , 1992, Nature.

[22]  M. Mannie,et al.  MHC class-II-restricted antigen presentation by myelin basic protein-specific CD4+ T cells causes prolonged desensitization and outgrowth of CD4- responders. , 2001, Cellular immunology.

[23]  T. Wyss-Coray,et al.  Antigen‐presenting human T cells and antigen‐presenting B cells induce a similar cytokine profile in specific T cell clones , 1993, European journal of immunology.

[24]  T. Wyss-Coray,et al.  Use of antibody/peptide constructs of direct antigenic peptides to T cells: evidence for T cell processing and presentation. , 1992, Cellular immunology.

[25]  R. Winchester,et al.  Ia determinants on stimulated human T lymphocytes. Occurrence on mitogen- and antigen-activated T cells , 1979, The Journal of experimental medicine.

[26]  R. Doebele,et al.  Accessory molecules for MHC class II peptide loading. , 2000, Current opinion in immunology.

[27]  D. Sansom,et al.  B7/BB1, the ligand for CD28, is expressed on repeatedly activated human T cells in vitro , 1993, European journal of immunology.

[28]  G. Schieven,et al.  HLA-DR molecules enhance signal transduction through the CD3/Ti complex in activated T cells. , 1991, Tissue antigens.

[29]  E. Yunis,et al.  Peripheral human T cells sensitized in mixed leukocyte culture synthesize and express Ia-like antigens , 1978, The Journal of experimental medicine.

[30]  D. E. Anderson,et al.  Expression of a hypoglycosylated form of CD86 (B7-2) on human T cells with altered binding properties to CD28 and CTLA-4. , 1997, Journal of immunology.

[31]  Abraham Kupfer,et al.  TCR-Induced Transmembrane Signaling by Peptide/MHC Class II Via Associated Ig-α/β Dimers , 2001 .

[32]  W. Reith,et al.  Deregulated MHC Class II Transactivator Expression Leads to a Strong Th2 Bias in CD4+ T Lymphocytes 1 , 2003, The Journal of Immunology.

[33]  J. Roth,et al.  Increased MHC class II and CD25 expression on lymphocytes in the absence of persistent lymphocytosis in cattle experimentally infected with bovine leukemia virus. , 1998, Veterinary immunology and immunopathology.

[34]  C. Morton,et al.  Antiproliferative mechanism of anti-class II monoclonal antibodies. , 1989, Cellular immunology.

[35]  H. Mitsuya,et al.  Cross-linking HLA-DR molecules on Th1 cells induces anergy in association with increased level of cyclin-dependent kinase inhibitor p27(Kip1). , 2002, Immunology letters.

[36]  C. Benoist,et al.  Regulation of major histocompatibility complex class-II genes: X, Y and other letters of the alphabet. , 1990, Annual review of immunology.

[37]  O. Janssen,et al.  Growth inhibition of Epstein-Barr virus-transformed B cells by anti-HLA-DR antibody L243: possible relationship to L243-induced down-regulation of CD23 antigen expression. , 1989, Cellular immunology.

[38]  A. Langerak,et al.  Regulation of MHC class II expression in human T-cell malignancies. , 2004, Blood.

[39]  J. Trowsdale,et al.  In Vivo and In Vitro Modulation of HLA-DM and HLA-DO Is Induced by B Lymphocyte Activation1 , 2001, The Journal of Immunology.

[40]  P. J. van den Elsen,et al.  DNA methylation and expression of major histocompatibility complex class I and class II transactivator genes in human developmental tumor cells and in T cell malignancies. , 2003, Clinical immunology.

[41]  R. Lechler,et al.  Anergic T cells act as suppressor cells in vitro and in vivo , 1999, European journal of immunology.

[42]  R. Dudek,et al.  Intercellular exchange of class II MHC complexes: ultrastructural localization and functional presentation of adsorbed I-A/peptide complexes. , 2001, Cellular immunology.

[43]  M. Jenkins,et al.  Class II MHC-bearing keratinocytes induce antigen-specific unresponsiveness in hapten-specific Th1 clones. , 1988, Journal of immunology.

[44]  P. J. van den Elsen,et al.  Activated Human T Cells Accomplish MHC Class II Expression Through T Cell-Specific Occupation of Class II Transactivator Promoter III1 , 2002, The Journal of Immunology.

[45]  J. Freed,et al.  Ligation of major histocompatibility complex class II molecules mediates apoptotic cell death in resting B lymphocytes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[46]  F. Momburg,et al.  HLA-DM, HLA-DO and tapasin: functional similarities and differences. , 2002, Current opinion in immunology.

[47]  M. Feldmann,et al.  Human T cell clones present antigen. , 1989, Journal of immunology.

[48]  A. Singer,et al.  Cell surface appearance of unexpected host MHC determinants on thymocytes from radiation bone marrow chimeras. , 1981, Journal of immunology.

[49]  M. Loken,et al.  I-A antigens on cloned alloreactive murine T lymphocytes are acquired passively. , 1982, Journal of immunology.

[50]  S. Matsushita,et al.  Ligation of HLA-DR Molecules on B Cells Induces Enhanced Expression of IgM Heavy Chain Genes in Association with Syk Activation* , 2000, The Journal of Biological Chemistry.

[51]  P. J. van den Elsen,et al.  Shared regulatory elements in the promoters of MHC class I and class II genes. , 1998, Immunology today.

[52]  D. Hafler,et al.  Presentation of autoantigen by human T cells. , 1991, Journal of immunology.

[53]  M. Mannie,et al.  Acquisition of functional MHC class II/peptide complexes by T cells during thymic development and CNS-directed pathogenesis. , 2002, Cellular immunology.

[54]  J. Chi,et al.  HLA-DR expression in human fetal thymocytes. , 1992, Human immunology.

[55]  J. Trowsdale,et al.  HLA-DO is a negative modulator of HLA-DM-mediated MHC class II peptide loading , 1997, Current Biology.

[56]  M. Tesar,et al.  Fully human, HLA-DR-specific monoclonal antibodies efficiently induce programmed death of malignant lymphoid cells , 2002, Nature Medicine.

[57]  W. van Eden,et al.  Anergic T cells actively suppress T cell responses via the antigen‐presenting cell , 1998, European journal of immunology.

[58]  D. Charron,et al.  MHC class II isotype‐specific signaling complex on human B cells , 2002, European journal of immunology.

[59]  A. Lanzavecchia,et al.  T cells can present antigens such as HIV gp120 targeted to their own surface molecules , 1988, Nature.

[60]  D. Charron,et al.  A CD18-dependent protein kinase C beta-mediated alternative cell death pathway of activated monocytes. , 2002, International immunology.

[61]  C. Janeway,et al.  CIITA activates the expression of MHC class II genes in mouse T cells. , 1995, International immunology.

[62]  G. Schieven,et al.  Signal transduction by HLA-DR is mediated by tyrosine kinase(s) and regulated by CD45 in activated T cells. , 1991, Human immunology.

[63]  W. van Eden,et al.  Antigen presentation by T cells versus professional antigen‐presenting cells (APC): differential consequences for T cell activation and subsequent T cell‐APC interactions , 1999, European journal of immunology.

[64]  G. Groenewegen,et al.  Canine MHC-class II antigens on B and T lymphocytes. , 2008, Tissue antigens.

[65]  J. Monier,et al.  Anti-alpha chain monoclonal antibodies of equine MHC class-II antigens: applications to equine infectious anaemia. , 1997, Research in veterinary science.

[66]  T. Wyss-Coray,et al.  Discrimination of human CD4 T cell clones based on their reactivity with antigen‐presenting T cells , 1992, European journal of immunology.

[67]  S. Matsushita,et al.  Monocytes Are Differentially Activated Through HLA-DR, -DQ, and -DP Molecules Via Mitogen-Activated Protein Kinases1 , 2001, The Journal of Immunology.

[68]  F. Deist,et al.  HLA class II-mediated death is induced via Fas/Fas ligand interactions in human splenic B lymphocytes. , 1997, Blood.

[69]  G. Freeman,et al.  The B7–CD28 superfamily , 2002, Nature Reviews Immunology.

[70]  L. Racioppi,et al.  HLA class II molecules transduce accessory signals affecting the CD3 but not the interleukin-2 activation pathway in T blasts. , 1993, Human immunology.

[71]  D. H. Burgess,et al.  A caspase-independent pathway of MHC class II antigen-mediated apoptosis of human B lymphocytes. , 1999, Journal of immunology.

[72]  R. Lechler,et al.  Human T cells cannot act as autonomous antigen-presenting cells, but induce tolerance in antigen-specific and alloreactive responder cells , 1992, The Journal of experimental medicine.

[73]  T. Wyss-Coray,et al.  The B7 adhesion molecule is expressed on activated human T cells: Functional involvement in T‐T cell interactions , 1993, European journal of immunology.

[74]  C. Issel,et al.  General method for the detection and in vitro expansion of equine cytolytic T lymphocytes. , 1998, Journal of immunological methods.

[75]  E. Choi,et al.  Thymocytes positively select thymocytes in human system. , 1997, Human immunology.

[76]  L. Lanier,et al.  Functional expression of B7/BB1 on activated T lymphocytes , 1993, The Journal of experimental medicine.

[77]  W. Reith,et al.  The bare lymphocyte syndrome and the regulation of MHC expression. , 2001, Annual review of immunology.

[78]  G. Bishop,et al.  Signaling Through MHC Class II Molecules Blocks CD95-Induced Apoptosis1 , 2001, The Journal of Immunology.

[79]  R. Lechler,et al.  Interferon-γ-treated renal tubular epithelial cells induce allospecific tolerance , 1998 .

[80]  D. Charron,et al.  Lymphocyte programmed cell death is mediated via HLA class II DR. , 1994, International immunology.